🇺🇸 FDA
Patent

US 8618331

Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

granted A61KA61K31/502A61P

Quick answer

US patent 8618331 (Polycyclic heteroaryl substituted triazoles useful as axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/502, A61P, A61P1/04, A61P11/00